XML 30 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Subsequent Event
3 Months Ended
Mar. 31, 2025
Subsequent Events [Abstract]  
Subsequent Event

13. Subsequent Event

In May 2025, the Company determined to discontinue two research programs under a license and collaboration agreement with Stoke. Under the agreement, the licenses to the discontinued programs, which are the MECP2 program for Rett syndrome and a program for an undisclosed neurodevelopmental target, will terminate and the parties will wind down the activities for the two programs.